Connect with us

Hi, what are you looking for?

Stock

UK’s CMA may accept Synopsys/Ansys deal remedies

Investing.com — The UK’s Competition and Markets Authority (CMA) said it may accept the remedies offered by Synopsys (NASDAQ:SNPS) and Ansys (NASDAQ:ANSS). The agency now has until until March 5, 2025 to make an official decision. The undertakings, offered by both companies at the end of last year on December 31, include the divestment of certain product lines.

Specifically, Ansys has proposed to divest its product for power consumption analysis of digital chips. On the other hand, Synopsys has offered to divest its Optical Solutions Group. The CMA has stated that there are reasonable grounds to believe that these undertakings might be accepted.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

This post appeared first on investing.com

    You May Also Like

    Editor's Pick

    Adani Group shares experienced a rebound on Monday, recovering from last week’s steep losses sparked by U.S. criminal charges against Chairman Gautam Adani and...

    Investing

    A rogue employee was responsible for hiding $151 million in delivery expenses over the course of nearly three years, Macy’s said Wednesday. In a...

    Editor's Pick

    Kohl’s Corporation (NYSE: KSS) shares plunged 11% following a disappointing Q3 earnings report and a sharp downgrade of its fiscal 2024 outlook. The department...

    Editor's Pick

    Stock futures climbed on Wednesday, driven by strong performances from Salesforce and Marvell Technology, following upbeat quarterly earnings. Futures tied to the Dow Jones...



    Disclaimer: Techreportdiversity.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 Techreportdiversity.com